X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with WYETH LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs WYETH LTD - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD WYETH LTD ORCHID PHARMA LTD/
WYETH LTD
 
P/E (TTM) x -0.8 27.7 - View Chart
P/BV x 0.5 5.3 10.2% View Chart
Dividend Yield % 0.0 1.3 -  

Financials

 ORCHID PHARMA LTD   WYETH LTD
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
WYETH LTD
Mar-13
ORCHID PHARMA LTD/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs1941,044 18.6%   
Low Rs35818 4.3%   
Sales per share (Unadj.) Rs276.5298.6 92.6%  
Earnings per share (Unadj.) Rs-79.257.2 -138.4%  
Cash flow per share (Unadj.) Rs-43.558.4 -74.4%  
Dividends per share (Unadj.) Rs017.00 0.0%  
Dividend yield (eoy) %01.8 0.0%  
Book value per share (Unadj.) Rs53.9249.5 21.6%  
Shares outstanding (eoy) m70.4522.72 310.1%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.43.1 13.3%   
Avg P/E ratio x-1.416.3 -8.9%  
P/CF ratio (eoy) x-2.615.9 -16.5%  
Price / Book Value ratio x2.13.7 56.9%  
Dividend payout %029.7 0.0%   
Avg Mkt Cap Rs m8,06721,157 38.1%   
No. of employees `0002.80.5 569.1%   
Total wages/salary Rs m2,527400 631.8%   
Avg. sales/employee Rs Th6,956.113,787.4 50.5%   
Avg. wages/employee Rs Th902.5813.0 111.0%   
Avg. net profit/employee Rs Th-1,993.02,643.3 -75.4%   
INCOME DATA
Net Sales Rs m19,4776,783 287.1%  
Other income Rs m407353 115.5%   
Total revenues Rs m19,8847,136 278.6%   
Gross profit Rs m1,1031,617 68.2%  
Depreciation Rs m2,51927 9,470.7%   
Interest Rs m5,2276 95,032.7%   
Profit before tax Rs m-6,2361,938 -321.8%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m511-5 -10,019.6%   
Tax Rs m-125632 -19.8%   
Profit after tax Rs m-5,5801,301 -429.1%  
Gross profit margin %5.723.8 23.7%  
Effective tax rate %2.032.6 6.2%   
Net profit margin %-28.719.2 -149.4%  
BALANCE SHEET DATA
Current assets Rs m11,0146,984 157.7%   
Current liabilities Rs m32,0602,056 1,559.4%   
Net working cap to sales %-108.172.6 -148.7%  
Current ratio x0.33.4 10.1%  
Inventory Days Days9599 95.6%  
Debtors Days Days3424 140.2%  
Net fixed assets Rs m29,440244 12,050.7%   
Share capital Rs m705227 310.1%   
"Free" reserves Rs m2,0435,441 37.5%   
Net worth Rs m3,8005,668 67.0%   
Long term debt Rs m9,01825 36,071.6%   
Total assets Rs m46,5107,901 588.7%  
Interest coverage x-0.2353.3 -0.1%   
Debt to equity ratio x2.40 53,805.1%  
Sales to assets ratio x0.40.9 48.8%   
Return on assets %-0.816.5 -4.6%  
Return on equity %-146.922.9 -640.0%  
Return on capital %-3.734.0 -11.0%  
Exports to sales %37.90.2 17,361.2%   
Imports to sales %22.636.3 62.2%   
Exports (fob) Rs m7,37815 49,848.6%   
Imports (cif) Rs m4,4062,465 178.7%   
Fx inflow Rs m7,51315 49,429.6%   
Fx outflow Rs m5,6492,677 211.0%   
Net fx Rs m1,865-2,662 -70.0%   
CASH FLOW
From Operations Rs m1,682923 182.2%  
From Investments Rs m-9,860317 -3,111.5%  
From Financial Activity Rs m6,644-481 -1,381.2%  
Net Cashflow Rs m-1,535759 -202.2%  

Share Holding

Indian Promoters % 32.3 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 4.6 11.3 40.7%  
FIIs % 3.3 7.2 45.8%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 30.4 181.9%  
Shareholders   84,811 21,978 385.9%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   TTK HEALTHCARE  UNICHEM LAB  STERLING BIOTECH  ELDER PHARMA  ALEMBIC LTD  

Compare ORCHID PHARMA LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Infosys Woes, Insurance IPOs and Top Stocks in Action(Pre-Open)

On Monday, the share markets in India slumped in the final hours of trade and finished the day in red.The BSE Sensex closed lower by 266 points to end at 31,259.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Aug 21, 2017 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 8-QTR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS